Webinar

How early-phase modeling provides better, faster pricing and development strategies

  • PharmaLex, a Cencora company

Summer Shorts Webinar Series
Early-phase modeling (EPM) offers valuable insights and guidance on critical factors influencing pricing potential for products much earlier in the development cycle than traditional methods.

Key insights

Learn from our speakers to explore how advanced visibility into product costs and effectiveness can significantly benefit organizations in several key areas. This approach facilitates the development of pricing and reimbursement strategies, assesses the impact of various outcomes from planned or ongoing clinical studies, and helps identify data gaps in clinical trials. Additionally, it allows organizations to explore value before clinical trial data is available, guiding decisions regarding further research and development. We'll also cover how to identify potential challenges in early-stage development and determine the relative importance of different parameters. Chris Englerth, our Director of Global Consulting Services, moderated this session alongside Annabelle Forsmark, our Associate Director of Market Access and Healthcare Consulting.

Summer Shorts

Access the recording

Pardot Form

Connect with our team

Our team of leading value experts is dedicated to transforming evidence, policy insights, and market intelligence into effective global market access strategies. Let us help you navigate today’s complex healthcare landscape with confidence. Reach out to discover how we can support your goals.

Related resources

Newsletter

HTA Quarterly Spring 2026

Webinar

Preparing for 2026 health policy changes and their impact on pricing, affordability, and access

Article

CGT access: Managing risk at scale